FDA plans to limit COVID vaccine to only high-risk people
Digest more
FDA announces cucumber recall
Digest more
The affected medicines include cetirizine, which is popularly sold under the brand name Zyrtec, and levocetirizine, sold as Xyzal.Start the day smarter. Get all the news you need in your inbox each morning.
The FDA recently published a warning about these antihistamines, saying that patients who suddenly stop taking these medicines after long-term use "may experience rare but severe itching." The itching,
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound).
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
Explore more
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter.
17h
MedPage Today on MSNFDA Chief Defends Job Cuts, COVID Booster Policy at Senate HearingSeven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes acrimonious questions from Senators about agency staffing cuts, limits on COVID boosters, and more.
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
By Stephanie Brown HealthDay ReporterTHURSDAY, May 22, 2025 (HealthDay News) -- In February of this year, the U.S. Food and Drug Administration and U.S. Customs and Border Protection seized nearly 2 million units of unauthorized electronic cigarette products in Chicago.
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic lung disease commonly known as "smoker's lung", the company said on Thursday.
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in the United States have come to rely on.